Medpace, of Cincinnati, is a mid-sized full-service contract research organisation whose physician-led model keeps medical oversight, the imaging core laboratory and central laboratories in-house, a package that biotechnology companies buy for oncology programmes. Whether in-house imaging and laboratories give cleaner oncology endpoints than outsourcing is unproven.
Medpace, based in Cincinnati and listed as MEDP, is a mid-sized full-service contract research organisation whose clients are mostly biotechnology companies, including for oncology programmes. Its physician-led model keeps medical oversight in-house, as are its imaging core laboratory and central laboratories. OnCo links it to contract research organisations and to imaging core labs and central review. Whether keeping imaging and laboratory work in-house gives cleaner oncology endpoints than outsourcing them is the argument behind its model and the open question. The CRO technology page carries the wider picture.
Shares Contract research organisations (CROs), Imaging core labs and central review and the tag supporting.
Shares Imaging core labs and central review and the tag supporting.
Shares Contract research organisations (CROs) and the tag supporting.
Shares Contract research organisations (CROs) and the tag supporting.
Shares Imaging core labs and central review and the tag supporting.
Shares Contract research organisations (CROs) and the tag supporting.
Shares Contract research organisations (CROs) and the tag supporting.
Shares Contract research organisations (CROs) and the tag supporting.